Difference between revisions of "Ramosetron (Iribo)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 5: | Line 5: | ||
*'''Brand names:''' IBset, Iribo, Nasea, Nozia | *'''Brand names:''' IBset, Iribo, Nasea, Nozia | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
Revision as of 22:48, 13 June 2018
Mechanism of action
Serotonin 5-HT3 receptor antagonist with antiemetic properties. No known antineoplastic properties. Not FDA-approved; available in Japan and Southeast Asia.
Also known as
- Brand names: IBset, Iribo, Nasea, Nozia